Ovarian Cancer p53 Mutation Is Associated with Tumor Microvessel Density
- 1 July 2002
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 86 (1) , 85-90
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancerCancer Gene Therapy, 2002
- The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancerSeminars in Oncology, 2001
- p53 Mutations and Expression in Ovarian CancersInternational Journal of Gynecological Pathology, 1999
- Angiogenesis as a Predictor of Long-term Survival for Patients With Node-Negative Breast CancerJNCI: Journal of the National Cancer Institute, 1996
- Microvessel count predicts metastatic disease and survival in non‐small cell lung cancerThe Journal of Pathology, 1995
- Clonal Origin of Epithelial Ovarian Carcinoma: Analysis by Loss of Heterozygosity, p53 Mutation, and X-Chromosome InactivationJNCI: Journal of the National Cancer Institute, 1992
- Oncogenic forms of p53 inhibit p53-regulated gene expressionScience, 1992
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989
- Tumor-related angiogenesisCritical Reviews in Oncology/Hematology, 1989
- Angiogenic FactorsScience, 1987